Mereo BioPharma Group

MREO | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.49

-$0.04 (-7.04%)

At close: Jan 26, 2026, 3:55 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-7.04%

(1D)

Key Statistics

Market Data

Market Cap $78.57M

1D Range

0.48 0.52

52W Range

0.20 3.26

Valuation (TTM)

PE -2.03

PB 1.81

EV/EBITDA -0.83

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target $0.83

Cash Flow

FCF Yield -46.2%

SBC Adj. FCF Yield N/A

SBC Impact -17.7%

Margins

Gross Margin 19.1%

Operating Margin -9369.9%

FCF Margin -7777.4%

Growth (CAGR)

Revenue 3Y | 5Y -33.3% | N/A

Dil EPS 3Y | 5Y -33.4% | 20.0%

FCF 3Y | 5Y -110.1% | 8.9%

Returns

ROA -77.4%

ROE -74.8%

ROIC -96.3%

Financial Health

Net Cash

$48.3M

Current Ratio 8.71

Interest Coverage -77.20

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead pro...

Sector Healthcare

Industry Biotechnology

Employees 36

IPO Date Apr 23, 2019

Website www.mereobiopharma.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.